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Nocturnal Asthma* 
ß2-Adrenoceptors on Peripheral Mononuclear 
Leukocytes, cAMP- and Cortisol-Plasma 
Concentrations 
Ekkehard Haen, M.D., M.S.; Rainer Hauck, M.D.; 
Hans Peter Emslander, M.D.; Irmgard Langenmayer, M.D.; 
Bernhard Liebl, M.D.; Jochen Schopohl, M.D.;Jörg Kemieny M.D.; and 
Günter Fruhmann, M.D., EC.CP. 
To evaluate pathophysiologic mechanisms of the predomi-
nantly nocturnal complaints in atopic bronchial asthma, the 
expression and function of ß2-adrenoceptors on peripheral 
mononuclear leukocytes (pMNL), the cAMP,—as well as 
the Cortisol—plasma concentrations were studied in eight 
healthy men and ten so far untreated male asthmatic 
patients at 4-h intervals for 24 h. No difference was seen in 
the ß 2-adrenoceptor density (Bmax) on pMNL between 
healthy and asthmatic men (24-h means ± S E : 908 ± 59 sites 
per cell and 821 ± 5 4 sites per cell, respectively). The 
equilibrium dissociation constant (Kd), however, was signif-
icantly higher in the asthmatic patients (24-h mean±SE: 
8.8 ± 1 . 2 pmol/L vs 3.0 ± 0 . 2 pmol/L in healthy men, 
p<0.0001), which is equivalent to a lower affinity of the ß 2 -
adrenoceptors for the radioligand 125iodocyanopindolol. 
Bmax showed a statistically significant circadian variation, 
but Kd did not. The circadian variation in Bmax was 
reflected in the basal intracellular cyclic adenosine-mono-
phosphate (cAMP) content of the cells investigated. High 
Kd values (equivalent to low receptor affinities) tended to 
be associated with small increases of the intracellular cAMP 
content after in vitro stimulation by 10"7 mol/L isoprenaline 
(isoproterenol) (24-h m e a n ± S E : 1.4 ± 0 . 2 pmol/ 106 cells; 
r = -0.529, p = 0.05 at r = -0.549, n = 10). Plasma cAMP 
concentrations were found to be significantly lower in the 
asthmatic patients (24-h means ± S E : 22.9 ± 1 . 3 nmol/L vs 
29.1 ± 1 . 1 nmol/L, p <0.0001). Plasma Cortisol concentra-
tions were significantly higher in the asthmatic patients (24-
h means ± S E : 0 . 5 0 0 ± 0 . 0 8 4 p,mol/L vs 0.319 ± 0 . 0 6 3 
|xmol/L). The results support the hypothesis that a lesion 
of the ß-adrenergic system contributes to the pathophysi-
ology of atopic bronchia] asthma. In the patients investigated 
in this study, such a lesion could be demonstrated in the 
affinity rather than in the number of ß2-adrenoceptors 
expressed on peripheral cells of the immune system 
(pMNL). According to present-day knowledge of adrenergic 
effects on pMNL, such an affinity decrease of ß2-adreno-
ceptors could account for overshooting immune reponses. 
In association with other factors influencing respiratory 
function, it could be responsible for the predominantly 
nocturnal complaints in atopic bronchial asthma. Plasma 
Cortisol concentrations did not appear to be related to the 
principal cause of "nocturnal asthma;" they rather reflected 
an endogenous defense mechanism to the disease. 
(Chest 1991; 100:1239-45) 
ANOVA = analysis of variance; Bmax = ß 2-adrenoceptor den-
sity; cAMP = cyclic adenosine monophosphate; IBMX = isobutyl 
methylxanthin; I 2 5 I - C Y P = ,25iodocyanopindolol; Kd = equilib-
rium dissociation constant; P D E = phosphodiesterase; P E F = 
peak expiratory flow; pMNL = peripheral mononuclear leuko-
cytes 
T J r o n c h i a l asthma is characterized by refractoriness 
against ß-adrenergic s t i m u l i . 1 Drugs ampl i fy ing 
the sympathetic tone (ß-sympathomimetic drugs, me-
thylxanthines) are most effective i n this disorder, 2 so 
that a disturbance of the expression and/or funct ion of 
ß - a d r e n o c e p t o r s was suggested as an u n d e r l y i n g 
cause. 1 T h i s t h e o r y has been the subject o f intense 
investigation; however, i t has not been possible to 
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ei ther reject or substantiate i t clearly. We are inter -
ested i n the circadian variat ion of asthmatic at tacks . 3 6 
Circadian variations i n the excretion of catechola-
mines, i n plasma adrenaline concentration, and i n 
plasma cyclic adenosine monophosphate (cAMP) con-
centrat ion have already been d e s c r i b e d 7 1 0 w i t h l o w 
values i n the early m o r n i n g matching the t i m e of 
increased asthmatic symptoms. As w e l l as these var-
iables, the n u m b e r and af f in i ty of ß 2 -adrenoceptors 
are necessary to f u l l y describe the sympathetic tone 
and its inf luence on the bronchia l tone. Recently we 
observed a circadian variat ion i n the ß 2 -adrenoceptor 
density (Bmax) expressed on per iphera l mononuclear 
leukocytes ( p M N L ) of healthy m e n . 1 1 A reduced ß 2 -
adrenoceptor density i n asthmatic patients has been 
a s s u m e d 1 2 1 3 b u t not yet substantiated convincingly. 
Previous investigations may have been biased by 
pretreatment of the patients under investigation, by 
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circadian variations of the physiologic variables s tud-
i e d , b y differences between male and female sub-
jects , 1 1 and by a conceptual error i n the analysis o f 
radiol igand receptor assays. 1 4 1 5 O n the other h a n d , 
the circadian variations o f plasma Cortisol concentra-
tions are also assumed to contr ibute to noc turna l 
a s t h m a . 5 1 6 1 7 We therefore studied the expression o f 
ß 2 -adrenoceptors on p M N L , the isoprenal ine- induced 
intracel lular c A M P product ion i n these cells, and the 
c A M P as w e l l as the Cortisol plasma concentrations o f 
so far untreated asthmatic m e n for 24 h . As cells o f 
the i m m u n e system, p M N L m i g h t be direc t ly involved 
i n the pathophysiology of atopic bronchial asthma. 
L i k e bronchial tissue, they bear ß-adrenoceptors o f 
the ß 2 - t y p e . 1 8 These cells may be s imply and repeat-
edly collected w i t h o u t undue discomfort for the pa-
t ient . They are therefore w i d e l y used i n cl inical studies 
on receptor disturbances i n bronchial a s t h m a . 1 9 2 3 
M A T E R I A L S AND M E T H O D S 
At 4-h intervals, 20 ml of venous blood was drawn from the 
antecubital vein of eight healthy men and ten male asthmatic 
patients. Seven healthy men and two asthmatic patients were 
hospitalized in the Clinical Research Unit of the Walther-Straub-
Institute; one healthy man and three asthmatic patients were 
hospitalized in the I . Medical Clinic of the Technical University, 
the other five patients were hospitalized in the I . Medical Clinic 
Großhadern of the Ludwig-Maximilians-University of Munich. 
Collection of blood, lung function testing, and handling of blood 
specimens were always done by the staff of the Walther-Straub-
Institute. All laboratory tests were performed in the Walther-
Straub-Institute; only plasma Cortisol was assayed in Dr. Schopohls 
laboratory. 
The healthy subjects (22 to 34 years of age) had a negative history 
and showed no signs of allergic, pulmonary, cardiac, renal, and 
hepatic disease, nor of any other disease by clinical inspection. Total 
plasma IgE concentrations were below 120 kU/L. The asthmatic 
patients were 19 to 33 years of age. They had never been consistently 
treated for their complaints, which implies that their asthma was of 
a mild type. Some of them had occasionally used medications, 
inhaled ß-sympathomimetic or vagolytic drugs (less than one or two 
puffs within three weeks), and/or antihistamines, but usually over-
came their symptoms without medication. They were referred from 
private practices to the participating hospitals for diagnostic check-
ups. They complained of breathlessness and coughing predomi-
nantly at nighttime. Their respiratory function was monitored over 
the period under investigation by a computer-based bedside spiro-
meter providing full flow/volume spirometry (Spiropro 3000, Gans-
horn Electronic GmbH, Münnerstadt/FRG) in five patients (pa-
tients hospitalized at the I. Medical Clinic of the Technical 
University and at the Clinical Research Unit of the Walther-Straub-
Institute) and by oscillatory aiway resistance (Raw, Siregnost F D 
5, Siemens AG, Erlangen/FRG) in the other five patients (hospital-
ized at the I . Medical Clinic Großhadern of the Ludwigs-Maximil-
ians-University); measurements were performed immediately after 
drawing blood. The atopic nature of their asthma was verified by 
anamnesis, positive skin tests, demonstration of specific IgE anti-
bodies, and by exposure to the antigen in question. The repeated 
assessment of respiratory function at 4-h intervals allowed the 
documentation of bronchial obstruction and its spontaneous revers-
ibility (Fig 1). 
The study was approved by the ethical committee of the hospital 
of the Technical University of Munich and informed consent was 
obtained. The subjects were hospitalized for the full length of the 
investigation. They continued to follow their regular lifestyle, which 
they had recorded for the week preceding the study. On the average, 
they slept from 11 P M to 7 A M , and meals were served at 8 A M , 
11:30 A M , and 5:30 P M . During the day, the subjects did not stay in 
bed, but either did some paper work, read, or went for short walks. 
Blood was drawn after 30 min of rest in the supine position. No 
drugs were taken. 
Directly after venipuncture, intact pMNL were harvested by 
density centrifugation (using Lympho-paque, Nyegaard & Co, AS, 
Oslo/Norway). The expression of ß,-adrenoceptors was studied for 
each time point in radioreceptor assays as described elsewhere.'5 
In brief, p M N L were incubated for 2 h at 37°C with 12 concentra-
tions of (- )-125iodocyanopindolol ( l 2 5 I-CYP, Amersham Buchler, 
Braunschweig/FRG) in the range of 1.0 to 150.0 pmol/L to determine 
the number of high affinity binding sites (Bmax) and their equilib-
rium dissociation constant (Kd). Nonspecific binding was deter-
mined in parallel incubations with 10"5 mol/L (— )-timolol. Pipetting 
was performed (by aTecan Robotic Sample Processor Model 5052, 
dual arm system, Tecan AG Frankfurt/FRG). 2 4 A binding equation 
for two independent classes of binding sites was fitted to the data, 
using a nonlinear iteration procedure. 1 ' 1 5 
The function of ß2-adrenoceptors on pMNL was tested in the 
asthmatic patients by stimulating the intracellular cAMP content 
with 10"7 mol/L isoprenaline (isoproterenol) over basal values 
(incubation with buffer) for 10 min at 37°C. The cells were 
preincubated for 30 min at room temperature with 10~4 mol/L 
isobutylmethylxanthin (IBMX) to inhibit the degradation of intra-
cellularly formed cAMP by the enzyme phosphodiesterase (PDE). 
The incubation with isoprenaline was stopped by placing the cell 
suspensions for 5 min in boiling water to rupture the cells. Cell 
I / m i n 
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F I G U R E 1. Mean circadian variation in peak expiratory flow (top 
panel) and in oscillatory airway resistance (bottom panel) of five so 
far untreated male asthmatic patients. 
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F I G U R E 2. Mean circadian variation in the expression 
of ß2-adrenoceptors (Bmax) on peripheral mononuclear 
leukocytes (pMNL) of 10 so far untreated male asth-
matic patients, 19 to 33 years of age, and 8 healthy 
men, 22 to 34 years of age. 
particulates were centrifuged for 5 min at 15,000g and the super-
natant stored at — 20°C until determination of the cAMP content. 
Intracellular cAMP, plasma cAMP, and plasma Cortisol were deter-
mined by radioimmunoassay (Amersham Buchler, Braunschweig/ 
F R G and D R G Instruments GmbH, Marburg/FRG, respectively). 
Mean values are given with their standard errors (SE). The 24-h 
mean was defined as the mean of each set of raw data within 24 h, 
the cirpadian range as the difference between its maximal and 
minimal value, and the circadian variation as the time-specified 
pattern of variation observed over 24 h. Time of day effects were 
statistically validated by an analysis of variance (ANOV\) with 
subjects and time of day as components. Correlations between 
mean values were tested by linear regression analysis. To test for 
differences between asthmatic patients and healthy men, a Students 
t test was used. The significance level used was a = 0.05. 
R E S U L T S 
Respiratory func t ion tests revealed a m i l d f o r m of 
asthma i n the ten male patients (peak expiratory flow 
[ P E F ] 24-h m e a n ± S E : 4 9 4 ± 2 1 L/min, Raw 24-h 
m e a n ± S E : 3 . 8 ± 0 . 2 2 kPaXs/L). A l l o f the asthma 
patients, however, showed a marked nocturnal d i p , 
even i f the i r respiratory funct ion was i n the normal 
range d u r i n g dayt ime. This was apparent i n b o t h P E F 
( 1 7 . 7 ± 4 . 8 percent o f the 24-h mean at 6 AM , top 
panel i n F i g 1) and oscillatory airway resistance 
(18.4 ± 5 . 9 percent of the 24-h mean at 2 A M , b o t t o m 
panel i n F i g 1). T h e spontaneous reversibi l i ty of the 
nocturnal d i p was demonstrated i n each patient . 
Statistically significant t i m e o f day effects were 
observed i n the circadian variat ion of the ß 2 -adreno-
ceptor density on p M N L i n the healthy controls 
(ANOVA: p < 0 . 0 0 1 ; 24-h mean ± SE: 908 ± 59 sites per 
cel l ; c ircadian range: 71.6 to 126.9 percent o f the 
24-h mean), whereas i n the asthmatic patients, these 
effects w e r e n o t s t a t i s t i c a l l y s i g n i f i c a n t ( A N O V A : 
p = 0.077; 24-h m e a n ± S E : 821 ± 5 4 sites per cel l ; 
circadian range: 69.3 to 133.7 percent of the 24-h 
mean; F i g 2). I n b o t h groups, ß 2 -adrenoceptor density 
was lowest around m i d n i g h t . There were no statisti-
cally significant differences between healthy and asth-
matic subjects i n Bmax. 
N o statistically significant t i m e of day effects were 
observed i n the circadian variat ion o f the apparent 
e q u i l i b r i u m dissociation constant K d representing the 
af f ini ty o f the ß 2 -adrenoceptors for the radioligand 
1 2 5 I -CYP. I n the asthmatic patients, however, the af f in-
i t y was decreased over the whole study per iod (which 
F I G U R E 3. Mean circadian variation in the apparent 
equilibrium dissociation constant (Kd) for the radioli-
gand 1 ? 5iodocyanopindolol of ß 2-adrenoceptors ex-
pressed on peripheral mononuclear leukocytes (pMNL) 
of 10 so far untreated male asthmatic patients, 19 to 33 
years of age, and 8 healthy men, 22 to 34 years of age. 
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F I G U R E 4. Mean circadian variation in the basal cyclic 
adenosine monophosphate (cAMP) content of periph-
eral mononuclear leukocytes (pMNL) of 10 so far 
untreated male asthmatic patients, 19 to 33 years of 
age, and its stimulation by 1 0 " 7 mol/L isoprenaline. 
is equivalent to an increased K d value, F i g 3): The 
24-h mean ± SE was 8.8 ± 1 . 2 pmol/L i n the asthmatic 
patients as compared w i t h 3.0 ± 0 . 2 pmol/L i n the 
healthy controls (p<0.0001). 
The basal intracel lular c A M P content of p M N L 
der ived f r o m asthmatic patients reflected the circadian 
variat ion i n the ß 2 -adrenoceptor density expressed on 
t h e s e c e l l s ( A N O V A : p < 0 . 0 1 ; 2 4 - h m e a n ± S E : 
4.4 ± 0 . 3 pmol/10 6 cells; circadian range: 70.2 to 131.9 
percent of the 24-h mean, F i g 4). A f t e r isoprenaline 
st imulation, the 24-h mean of the intracel lular c A M P 
content increased b y 1.4 ± 0 . 2 pmol/10 6 cells (24-h 
m e a n ± S E , circadian range: 63.2 to 154.9 percent of 
the 24-h mean, F i g 4). Expressed as pmol/10 6 cells, 
s t imulat ion was highest at 6 AM and lowest at 2 PM; 
expressed as a percentage of the basal value, st imula-
t i o n was highest at the t i m e of lowest basal value (10 
PM : 168.8 percent of basal value) and lowest at the 
t i m e of highest basal value (2 PM : 120.8 and 118.6 
percent of basal value). W h e n the 24-h means were 
fitted b y a l inear regression, 28 percent of the total 
variat ion could be explained b y a negative correlat ion 
h e a l t h y m e n 
, 0 0 18 .00 22 00 02 ,00 06 00 10' 00 14 00 18' 00 
time ( h ) 
between the st imulat ion of intracel lular c A M P and 
the apparent e q u i l i b r i u m dissociation constant K d ; ie, 
h i g h K d values (equivalent to l o w receptor affinities) 
tended to be associated w i t h small increases of the 
intracel lular c A M P content after in vitro s t imulat ion 
by isoprenaline. T h e correlat ion coefficient was just 
be low the significance level ( r = —0.529; p = 0.05 at 
r = — 0.549, n = 10). The correlat ion between the s t im-
ulat ion of intracel lular c A M P and Bmax was not 
statistically significant (r = 0.0996). 
Statistically significant t i m e of day effects could also 
be demonstrated i n the circadian variat ion of c A M P 
p l a s m a c o n c e n t r a t i o n s i n b o t h h e a l t h y sub jec t s 
(ANOVA: p < 0 . 0 5 ) and asthmatic patients (ANOVA: 
p < 0 . 0 5 ) . The values were significantly lower for the 
asthmatic patients (24-h m e a n ± S E : 22.9 ± 1 . 3 nmol/ 
L ) c o m p a r e d w i t h t h e h e a l t h y c o n t r o l s ( 2 4 - h 
m e a n ± S E : 2 9 . 1 ± 1 . 1 nmol/L, p < 0 . 0 0 0 1 , F i g 5 ) . The 
circadian range for this variable was similar i n b o t h 
groups (healthy subjects: 87 .1 to 117.5 percent of 
24-h mean; asthmatic patients: 86.3 to 108.0 percent 
of 24-h mean). 
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F I G U R E 5. Mean circadian variation in the plasma cyclic 
1 8 ^ adenosine monophosphate (cAMP) concentration of 10 
so far untreated male asthmatic patients, 19 to 33 years 
of age, and 8 healthy men, 22 to 34 years of age. 
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F I G U R E 6. Mean circadian variation in the plasma 
Cortisol concentration of 10 so far untreated male 
asthmatic patients, 19 to 33 years of age, and 8 healthy 
men, 22 to 34 years of age. 
T h e circadian variat ion of plasma Cortisol concen-
trations showed statistically significant t i m e of day 
effects in b o t h healthy m e n (ANOVA: p<0 .001 ) and 
asthmatic subjects (ANOVA: p < 0 . 0 0 1 , F i g 6). The 
24-h mean was significantly lower i n the healthy 
controls (mean ± SE: 0.319 ± 0.063 |xmol/L) compared 
w i t h the asthmatic patients (mean ± SE: 0 . 5 0 0 ± 0 . 0 8 4 
ixmol/L , p < 0 . 0 1 ) . Plasma Cortisol c o n c e n t r a t i o n s 
dropped at n ight to 0.030 ± 0 . 0 1 4 p,mol/L i n the 
healthy controls, b u t only to 0.135 ± 0.039 |xmol/L i n 
the asthmatic patients. The circadian range was 9.6 to 
182.9 percent of the 24-h mean i n the healthy men, 
and just 27.6 to 148.2 percent of the 24-h mean i n the 
asthmatic patients. 
D I S C U S S I O N 
Studies on the pathophysiology of bronchial asthma 
are often biased b y some k i n d of pretreatment of the 
patients under investigation. I n this study, part icular 
care was taken i n the selection of untreated patients. 
To the best of our knowledge, expression and funct ion 
of ß 2 -adrenoceptors on p M N L were not inf luenced b y 
any k i n d of (pre)treatment. These patients are rather 
rare, at least i n academic centers. I t has to be po in ted 
out that , since the patients were able to manage their 
disease w i t h o u t any drugs, the i r disease was m i l d . The 
c l inical diagnosis, however, was unequivocal ly estab-
l ished i n each case. T h e conclusions that fo l low apply, 
s t r ic t ly speaking, jus t to this group of patients. They 
suggest an i m p o r t a n t aspect of the mul t i funct ional 
pathophysiologic condi t ion of bronchial asthma that 
may possibly only be observed i n untreated subjects. 
Plasma Cortisol was original ly d e t e r m i n e d as a marker 
for the circadian system. Results demonstrated that 
the circadian system of each individual in this study 
was synchronized to the 24-h day. 
I t has been suggested that bronchial asthma is 
caused by a malfunct ion of ß 2 -adrenoceptors . 1 Such as 
mal funct ion was often assumed to be a reduced 
receptor n u m b e r , 1 2 1 3 whereas the original hypothesis 
inc luded al l kinds of ß-adrenoceptor disturbances, 
even adenylate cyclase insufficiency. 1 I n our study, no 
difference i n the n u m b e r of ß 2 -adrenoceptor sites 
expressed on p M N L could be observed between 
healthy m e n and untreated male asthmatic patients of 
the same age group. We d i d detect , however, a reduced 
af f ini ty of these ß 2 -adrenoceptors for the radiol igand 
1 2 5 I - C Y P i n our asthmatic patients. This indicates a 
conformational change of the receptor prote in , al-
though i t does not prove at present, a reduced af f in i ty 
for the physiologic l igand adrenaline. 1 2 5 I - C Y P is a 
sympathetic antagonist that m i g h t b i n d to a site on 
the receptor pro te in di f ferent f r o m the agonist b i n d i n g 
site. A reduct ion i n the af f ini ty of ß 2 -adrenoceptors 
for 1 2 5 I - C Y P w i t h o u t concomitant change i n the ß 2 -
adrenoceptor density has already been repor ted by 
L i e b l et a l 2 5 under the inf luence of reducing agents. 
A l t h o u g h the significance of this latter finding for the 
pathophysiologic condi t ion of bronchial asthma is not 
clear at present, i t demonstrates yet another example 
of a f f in i ty changes i n ß 2 -adrenoceptors. 
In vitro s t imulat ion of intracel lular c A M P produc-
t i o n is used to test the f u n c t i o n of ß 2 -adrenoceptors 
de termined by radioreceptor assays. 2 6- 2 7 Both experi-
ments are p e r f o r m e d using the same p M N L cel l 
suspension. I n this study, the increase o f intracel lular 
c A M P tended to be negatively correlated to the 
e q u i l i b r i u m dissociation constant K d — i n other words, 
the lower the af f ini ty of ß 2 -adrenoceptors, the lower 
( in the same cells) the intracel lular increase of c A M P 
after in vitro s t imulat ion b y isoprenaline. 
Plasma c A M P concentrations i n our asthmatic pa-
tients were significantly lower than i n our healthy 
controls. According to H o l m e g a a r d , 2 8 50 percent of 
plasma c A M P results f r o m leakage out of cells express-
i n g ß-adrenoceptors; the other 50 percent presumably 
stem f r o m kidney cells under st imulat ion by parathor-
m o n e . 2 8 Plasma c A M P may therefore be used as a 
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crude , integral marker of the ß-adrenergic tone. 
A l t h o u g h t h i s has b e e n d o n e i n severa l l e a d i n g 
publications, to our knowledge, data for healthy sub-
jects and asthmatic patients have been never compared 
i n the same study. Barnes et a l 9 gave data for five 
asthmatic m e n whose bronchodilator medicat ion was 
stopped 48 h before the investigation. According to 
P E F measurements, the patients were suffering f r o m 
a more severe bronchial asthma than our patients; 
the ir plasma c A M P concentrations were even lower (8 
to 16 nmol/L) than plasma c A M P i n our patients. 
M i k u n i et a l 1 0 s tudied 13 healthy male subjects whose 
c A M P plasma concentrations were lower than i n our 
healthy control group, b u t s t i l l h igher than i n the 
asthmatic patients of Barnes et al (13.2 to 19.3 nmol/ 
L) . 
H o w could an aff ini ty decrease of ß 2 -adrenoceptors 
throughout 24 h contr ibute to " n o c t u r n a l asthma" i n 
our patients? A t n i gh t , a fa l l i n plasma a d r e n a l i n e 7 1 0 
and C o r t i s o l 5 1 6 1 7 concentrations as w e l l as i n the 
n u m b e r of ß 2 -adrenoceptors (this study) d i m i n i s h 
physiologically the effectiveness of endogenous b r o n -
chodilat ing mechanisms, whereas the act ivi ty of en-
dogenous bronchoconstrictors, such as the parasym-
pathetic system 2 and/or the histamine release, 9 is 
increased. A t that t i m e , the af f ini ty decrease of ß 2 -
adrenoceptors cannot be counterbalanced as eff i -
c ient ly as d u r i n g the dayt ime, thus g iv ing rise to 
asthmatic attacks. 
I n this study, the expression and funct ion of ß 2 -
adrenoceptors was studied on w h i t e b lood cells that 
may be easily and repeatedly collected w i t h o u t causing 
undue discomfort to the patient . Many investigations 
on the possible role of ß-adrenoceptors i n atopic 
bronchial asthma used p M N L as a k i n d of tissue m o d e l 
for bronchial t issue, 1 2 1 3 1 8 2 2 since i t is impossible to 
obtain h u m a n l u n g tissue for routine analyses, espe-
cially not for repeated investigations on the same 
i n d i v i d u a l as i n this study. The changes observed on 
these cells are assumed to occur i n the same way on 
ß 2 -adrenoceptors i n bronchial tissue. I n general, this 
w o r k i n g hypothesis is not even ment ioned explicitly. 
However, i t has not yet been convincingly demon-
strated that this approach is actually v a l i d . There are 
many good arguments i n favor of this assumption; 2 3 
however, there are also reports opposed to i t . 2 9 I t is 
un l ike ly that the characteristics o f ß 2 -adrenoceptors 
vary under physiologic conditions among receptors 
expressed i n dif ferent tissues of the body. L ikewise 
drugs should have the same effects on these receptors 
as long as they are administered systemically. I t is 
feasible, however, that pathologic mechanisms may 
affect jus t one populat ion of ß 2 -adrenoceptors. 
W i t h regard to this study, such considerations are 
less important . The reduced af f in i ty of ß 2 -adrenocep-
tors was studied i n cells collected f r o m b l o o d . I f such 
a reduced af f ini ty is biological ly significant, i t should 
result i n a reduced format ion of intracel lular cAMP, 
w h i c h i n t u r n , may leak to a lesser extent out of these 
cells in to the surrounding plasma. I n this study, b o t h 
the reduced af f ini ty as w e l l as the reduced c A M P 
concentrat ion i n plasma could be demonstrated i n the 
same individuals ; i n other words, a reduced sympa-
thetic tone was demonstrated i n two physiologic 
variables d i rec t ly in terre la ted , notwithstanding the 
type of cells investigated. E v e n i f our results s imply 
indicate a reduced sympathetic inf luence on l y m p h o -
cytes, they demonstrate that at least p M N L are 
exposed to a reduced sympathetic tone i n asthmatic 
patients. 
Moreover, such an interpreta t ion m i g h t be even 
more challenging. Atopic bronchial asthma is an aller-
gic and inf lammatory disease involv ing i m m u n e reac-
tions. The p M N L do take par t i n these reactions. The 
impact of the sympathetic system on i m m u n e functions 
exerted b y p M N L has been under investigation. A 
clear-cut concept has not yet emerged, b u t there has 
been m u c h speculation, mostly based on investigations 
of the role of intracel lular c A M P levels . 3 0 Available 
evidence points i n general to an i n h i b i t i o n of i m m u n e 
functions by an increasing intracel lular c A M P con-
t e n t . 3 0 A reduct ion i n af f ini ty o f ß 2 -adrenoceptors 
expressed on p M N L w o u l d therefore reduce this 
i n h i b i t i n g action leading to overshooting i m m u n e 
reactions: allergy and inf lammat ion . 
Decreasing Cortisol plasma concentrations are gen-
erally discussed as c o n t r i b u t i n g to " n o c t u r n a l asthma." 
However, no comparison has been made so far be-
tween healthy subjects and asthmatic patients i n the 
same study. We were unable to trace lower Cortisol 
plasma concentrations at n i g h t i n our asthmatic pa-
tients than i n our healthy controls. O n the contrary, 
p lasma Cortisol c o n c e n t r a t i o n s w e r e f o u n d to be 
higher ; there was a small , b u t statistically significant 
difference i n the 24-h mean and i n the early m o r n i n g 
values. We do i n t e r p r e t the higher Cortisol secretion 
i n our asthmatic patients as an endogenous defense 
reaction against the disease. I t has been suggested 
that the adminis trat ion of glucocorticoids may upreg-
ulate the expression of ß - a d r e n o c e p t o r s . 3 1 3 2 The ele-
vated Cortisol concentrat ion observed i n our asthmatic 
patients w o u l d then be necessary to mainta in the ß 2 -
adrenoceptor density i n the range observed i n our 
healthy controls. I f this assumption is not correct , then 
physiologic concentrations of glucocorticoids do not 
have any effect on the n u m b e r of ß-adrenoceptors. 
The "upregula t ion" observed after steroid administra-
t i o n 3 2 could be a mis interpretat ion of the circadian 
variat ion i n the expression of ß 2 -adrenoceptors on 
p M N L : Brodde et a l 3 2 administered prednisone at 
9 AM and d e t e r m i n e d the steroid effect on the ß 2 -
adrenoceptor density i n the afternoon. 
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The results of this study support the hypothesis o f 
a ß-adrenergic lesion c o n t r i b u t i n g to the pathophysi-
ologic condi t ion of atopic bronchial asthma. I n our 
patients, this lesion could be demonstrated i n the 
af f ini ty rather than i n the n u m b e r o f ß 2 -adrenoceptors. 
I f this ß-adrenergic lesion does not lead to a general 
reduct ion i n sympathetic tone b u t rather affects only 
p M N L , a d i s turbed modula t ion of i m m u n e responses 
b y the sympathetic system should be considered i n 
atopic bronchial asthma. 
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